期刊
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
卷 278, 期 3, 页码 C570-C581出版社
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpcell.2000.278.3.C570
关键词
hIK1 channel; rSK2 channel; chlorzoxazone; zoxazolamine; 1-ethyl-2-benzimidazolinone
资金
- NIDDK NIH HHS [DK-54941-01] Funding Source: Medline
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054941] Funding Source: NIH RePORTER
We previously characterized 1-ethyl-2-benzimidazolinone (1-EBIO), as well as the clinically useful benzoxazoles, chlorzoxazone (CZ), and zoxazolamine (ZOX), as pharmacological activators of the intermediate-conductance Ca2+-activated K+ channel, hIK1. The mechanism of activation of hIK1, as well as the highly homologous small-conductance, Ca2+-dependent K+ channel, rSK2, was determined following heterologous expression in Xenopus oocytes using two-electrode voltage clamp (TEVC) and excised, inside-out patch-damp techniques. 1-EBIO, CZ, and ZOX activated both hIK1 and rSK2 in TEVC and excised inside-out patch-clamp experiments. In excised, inside-out patches, 1-EBIO and CZ induced a concentration-dependent activation of hIK1, with half-maximal (K-1/2) values of 84 mu M and 98 mu M, respectively. Similarly, CZ activated rSK2 with a K-1/2 of 87 mu M. In the absence of CZ, the Ca2+-dependent: activation of hIK1 was best fit with a K-1/2 of 700 nM and a Hill coefficient (n) of 2.0. rSK2 was activated by Ca2+ with a K-1/2 of 700 nM and an n of 2.5. Addition of CZ had no effect on either the K-1/2 or n for Ca2+-dependent activation of either hIK1 or rSK2. Rather, CZ increased channel activity at all Ca2+ concentrations (V-max). Event-duration analysis revealed hIK1 was minimally described by two open and three closed times. Activation by 1-EBIO had no effect on tau(o1), tau(o2), or tau(c1), whereas tau(c2) and tau(c3) were reduced from 9.0 and 92.6 ms to 5.0 and 44.1 ms, respectively. In conclusion, we define 1-EBIO, CZ, and ZOX as the first known activators of hIK1 and rSK2. Openers of IK and SK channels may be therapeutically beneficial in cystic fibrosis and vascular diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据